1. A novel quantitative prognostic model for initially diagnosed non-small cell lung cancer with brain metastases
   Xiaohui Li et al, 2022, Cancer Cell International CrossRef
2. Letter to the Editor regarding “Predictive value of the neutrophil-to-lymphocyte ratio in patients with deep neck space infection secondary to acute bacterial tonsillitis”
   Satvinder Singh Bakshi, 2017, International Journal of Pediatric Otorhinolaryngology CrossRef
3. Can Platelet and Leukocyte Indicators Give Us an Idea about Distant Metastasis in Nasopharyngeal Cancer?
   Mitat Arıcıgil et al, 2017, Prague Medical Report CrossRef
4. High pretreatment neutrophil‐to‐lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta‐analysis
   Lin Yang et al, 2019, Head & Neck CrossRef
5. DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes
   Devin C. Koestler et al, 2017, Cancer Epidemiology, Biomarkers & Prevention CrossRef
6. Characterisation of ethnic differences in DNA methylation between UK-resident South Asians and Europeans
   Hannah R. Elliott et al, 2022, Clinical Epigenetics CrossRef
7. Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios as Prognostic Markers of Survival in Patients with Head and Neck Tumours—Results of a Retrospective Multicentric Study
   Zsuzsanna Szilasi et al, 2020, International Journal of Environmental Research and Public Health CrossRef
8. Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy
   Whitney A. Sumner et al, 2017, Journal of Translational Medicine CrossRef
9. Molecular immuno‐imaging improves tumor detection in head and neck cancer
   Jing‐Hui Li et al, 2022, The FASEB Journal CrossRef
10. Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan
    Daisuke Kawakita et al, 2017, Oncotarget CrossRef
11. Pre-treatment Neutrophil-to-Lymphocyte Ratio as a predictor for occult cervical metastasis in early stage (T1-T2 cN0) squamous cell carcinoma of the oral tongue
    Vincenzo Abbate et al, 2018, Surgical Oncology CrossRef
12. Prognostic Significance of Peripheral T‐Cell Subsets in Laryngeal Squamous Cell Carcinoma
    Filippo Marchi et al, 2019, Laryngoscope Investigative Otolaryngology CrossRef
13. Monitoring the neutrophil‐to‐lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer
    Ryuji Yasumatsu et al, 2019, Head & Neck CrossRef
14. Role and research progress of hematological markers in laryngeal squamous cell carcinoma
    Hui Qi, 2023, Diagnostic Pathology CrossRef
15. Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer
    Cédric Panje et al, 2017, BMC Cancer CrossRef
16. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis
    Yalian Yu et al, 2018, BMC Cancer CrossRef
17. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study
    Jae-Keun Cho et al, 2018, BMC Cancer CrossRef
18. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio
    Mario Turri-Zanoni et al, 2017, Head & Neck CrossRef
19. Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients
    Yann-Alexandre Vano et al, 2018, PLOS ONE CrossRef
20. Efficacy of the Evaluation of Inflammatory Markers for the Reduction of Negative Appendectomy Rates
    Fatih Mehmet Yazar et al, 2018, Indian Journal of Surgery CrossRef
21. Neutrophil‐to‐lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta‐analysis
    Tristan Tham et al, 2018, Head & Neck CrossRef
22. Methylation-derived inflammatory measures and lung cancer risk and survival
    Naisi Zhao et al, 2021, Clinical Epigenetics CrossRef
23. The evaluation of pretreatment neutrophil–lymphocyte ratio and derived neutrophil–lymphocyte ratio in patients with laryngeal neoplasms
    Gorkem Eskiizmir et al, 2019, Brazilian Journal of Otorhinolaryngology CrossRef
24. The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma
    Medine Kara et al, 2017, European Archives of Oto-Rhino-Laryngology CrossRef
25. Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma
    Bernhard J. Jank et al, 2019, European Archives of Oto-Rhino-Laryngology CrossRef
26. Immunotherapy in head and neck cancer: The great challenge of patient selection
    Martina Napolitano et al, 2019, Critical Reviews in Oncology/Hematology CrossRef